In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli

Clicks: 401
ID: 111306
1996
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
From 1991 to 1995, 8,975 nonfermentative gram-negative bacilli were isolated from patients at The Ohio State University Medical Center: 71% Pseudomonas aeruginosa, 14% Stenotrophomonas maltophilia, 7.6% Acinetobacter baumannii, and < 2% each of 25 other species. The MICs of trovafloxacin (CP-99,2 …
Reference Key
rj1996antimicrobialin Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Fass RJ;Barnishan J;Solomon MC;Ayers LW;;
Journal Antimicrobial agents and chemotherapy
Year 1996
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8726011
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't Comparative Study microbial sensitivity tests anti-bacterial agents / pharmacology* gram-negative bacteria / isolation & purification anti-infective agents / pharmacology* pmid:8726011 pmc163341 doi:10.1128/aac.40.6.1412 r j fass j barnishan l w ayers fluoroquinolones gram-negative bacteria / drug effects* tobramycin / pharmacology* trimethoprim sulfamethoxazole drug combination / pharmacology* beta-lactams

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.